Migraine clinical trials at UCSD
1 in progress, 0 open to eligible people
Sorry, accepting new patients by invitation only
This pilot crossover study will evaluate 3 different potencies of inhaled cannabis (2.5%, 5%, and 10%) and inhaled placebo cannabis for the acute treatment of migraine.
La Jolla, California
Our lead scientists for Migraine research studies include Nathaniel M Schuster, MD.